These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2144641)

  • 41. Structure of IL-1 receptors.
    Dower SK; Bomzstyk K; Sims JE
    Prog Clin Biol Res; 1990; 349():241-9. PubMed ID: 2144637
    [No Abstract]   [Full Text] [Related]  

  • 42. HepG2 cells predominantly express the type II interleukin 1 receptor (biochemical and molecular characterization of the IL-1 receptor).
    Giri JG; Robb R; Wong WL; Horuk R
    Cytokine; 1992 Jan; 4(1):18-23. PubMed ID: 1319762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthetic C-terminal peptide of IL-1 functions as a binding domain as well as an antagonist for the IL-1 receptor.
    Palaszynski EW
    Biochem Biophys Res Commun; 1987 Aug; 147(1):204-11. PubMed ID: 2958006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding and internalization of the 163-171 fragment of human IL-1 beta.
    Boraschi D; Ghiara P; Scapigliati G; Villa L; Sette A; Tagliabue A
    Cytokine; 1992 May; 4(3):201-4. PubMed ID: 1386756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor.
    Mosley B; Urdal DL; Prickett KS; Larsen A; Cosman D; Conlon PJ; Gillis S; Dower SK
    J Biol Chem; 1987 Mar; 262(7):2941-4. PubMed ID: 2950091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Receptor-mediated endocytosis and nuclear transport of human interleukin 1 alpha.
    Grenfell S; Smithers N; Miller K; Solari R
    Biochem J; 1989 Dec; 264(3):813-22. PubMed ID: 2533500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Type I IL-1 receptor: ligand specific confirmation differences and the role of glycosylation in ligand binding.
    Einstein R; Jackson JR; D'Alessio K; Lillquist JS; Sathe G; Porter T; Young PR
    Cytokine; 1996 Mar; 8(3):206-13. PubMed ID: 8833035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A soluble binding protein specific for interleukin 1 beta is produced by activated mononuclear cells.
    Symons JA; Eastgate JA; Duff GW
    Cytokine; 1990 May; 2(3):190-8. PubMed ID: 2151765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for a low-affinity interleukin-3 receptor.
    Schreurs J; Arai K; Miyajima A
    Growth Factors; 1990; 2(2-3):221-33. PubMed ID: 2187495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The interleukin 1 receptor.
    Dinarello CA; Clark BD; Puren AJ; Savage N; Rosoff PM
    Immunol Today; 1989 Feb; 10(2):49-51. PubMed ID: 2526640
    [No Abstract]   [Full Text] [Related]  

  • 51. Similarity between the interleukin 1 receptors on a murine T-lymphoma cell line and on a murine fibroblast cell line.
    Dower SK; Call SM; Gillis S; Urdal DL
    Proc Natl Acad Sci U S A; 1986 Feb; 83(4):1060-4. PubMed ID: 2937055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Measurement of biologically active interleukin-1 by a soluble receptor binding assay.
    Riske F; Chizzonite R; Nunes P; Stern AS
    Anal Biochem; 1990 Mar; 185(2):206-12. PubMed ID: 2140248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of the plasma membrane receptor for interleukin-1 on mouse thymoma cells.
    Bron C; MacDonald HR
    FEBS Lett; 1987 Jul; 219(2):365-8. PubMed ID: 2956124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of interleukin-1 receptors on AtT-20 mouse pituitary tumour cells.
    Kobayashi H; Fukata J; Tominaga T; Murakami N; Fukushima M; Ebisui O; Segawa H; Nakai Y; Imura H
    FEBS Lett; 1992 Feb; 298(1):100-4. PubMed ID: 1312014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of a high-affinity receptor for interleukin-1 beta in rat brain.
    Katsuura G; Gottschall PE; Arimura A
    Biochem Biophys Res Commun; 1988 Oct; 156(1):61-7. PubMed ID: 2972289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human interleukin-1 alpha is chemotactic for normal human keratinocytes.
    Sauder DN; Orr FW; Matic S; Stetsko D; Parker KP; Chizzonite R; Kilian PL
    Immunol Lett; 1989 Aug; 22(2):123-7. PubMed ID: 2528505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coexpression of type I and type II IL-1 receptors in the murine T helper 2 cell line D10N.
    Brigelius-Flohé R; McCarthy JE; Resch K; Szamel M; Martin M
    FEBS Lett; 1993 Jul; 326(1-3):204-8. PubMed ID: 7686863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Murine interleukin-1 receptor: differences in binding properties between fibroblastic and thymoma cells and evidence for a two-chain receptor model.
    Bird TA; Gearing AJ; Saklatvala J
    FEBS Lett; 1987 Dec; 225(1-2):21-6. PubMed ID: 2961613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Independent binding of interleukin-1 alpha and interleukin-1 beta to type I and type II interleukin-1 receptors.
    Slack J; McMahan CJ; Waugh S; Schooley K; Spriggs MK; Sims JE; Dower SK
    J Biol Chem; 1993 Feb; 268(4):2513-24. PubMed ID: 8428929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences in internalization and intracellular processing of interleukin-1 associated with the two forms of interleukin-1 receptor found in B-cells and T-cells.
    Horuk R
    Biochem J; 1991 Jan; 273(Pt 1)(Pt 1):79-83. PubMed ID: 1824916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.